Accel Wealth Management

SEC CIK: 0001838226
Latest filing: Jul 10, 2026

SEC filings (opens in a new tab)

DNA holding history

Ginkgo Bioworks Holdings, Inc. in every 13F filed by Accel Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNA overview All 13F holders of DNA Full Q2 2026 holdings

Shares (Q3 2024): 0; Sold out in Q3 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q2 2024

Holdings of DNA by Accel Wealth Management, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2024	0	$0	0.0%	−359−100.0%	Sold outConverted for a 1-for-40 split	Holders
Q2 2024	14,350	$4.80K	<0.1%	+14,350	New	Holders